|
Meet the company poised to transform the cancer therapy landscape
[JP] Could reprogramming macrophages help fight cancer?Impressive pre-clinical trials by the Israeli pharmaceutical company have reaffirmed the concept of reprogramming macrophages for the treatment of some cancers. If it proves effective in current clinical trials, the concept could transform the cancer therapy landscape. Meet Enlivex Executive Chairman, Shai Novik, who has a decades-long track record in biotech and life sciences, including founding PROLOR Biotech, a company that developed a growth hormone for children, that eventually went public and was sold for $560 million. He also led the formation of a strategic partnership between PROLOR and Pfizer for continued development of the growth hormone drug during his time with the company. The drug, named NGENLA, has recently received marketing approvals in various jurisdictions including Australia, Canada, Japan and Europe. Now, Novik hopes to help treat cancer patients that don’t respond well to other treatments, such as chemotherapy or radiation. Posted by: Besoeker 2022-09-15 |
| http://www.rantburg.com/poparticle.php?ID=644099 |